VTA neurons show a potentially protective transcriptional response to MPTP

Brain Research

Volumn 1343, Issue , 2010, Pages 1-13

  Phani, Sudarshan ^a   Gonye, Gregory ^a   Iacovitti, Lorraine ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Microarray; Substantia nigra; Ventral tegmental area

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CARBONATE DEHYDRATASE IV; PANTOTHENATE KINASE 2; PROTEIN CAR4; PROTEIN PHF6; REGULATOR PROTEIN; RING FINGER PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EARLY RESPONSE GENE; GENE EXPRESSION; HOMEOSTASIS; LASER CAPTURE MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TRANSCRIPTION REGULATION; VENTRAL TEGMENTUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MICE; MICE, TRANSGENIC; NEURONS; NEUROTOXINS; PARKINSONIAN DISORDERS; TRANSCRIPTIONAL ACTIVATION; VENTRAL TEGMENTAL AREA;

PRIMATES; RODENTIA;

EID: 77953619085     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.061     Document Type: Article

References (45)

1. Alfahel-Kakunda A., and Silverman W.F. Calcium-binding proteins in the substantia nigra and ventral tegmental area during development: correlation with dopaminergic compartmentalization. Brain Res. Dev. Brain Res. 103 (1997) 9-20
2. Andersen J.K., Frim D.M., Isacson O., Beal M.F., and Breakefield X.O. Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). Brain Res. 656 (1994) 108-114
3. Begley T.P., Kinsland C., and Strauss E. The biosynthesis of coenzyme A in bacteria. Vitam. Horm. 61 (2001) 157-171
4. Bezard E., Dovero S., Bioulac B., and Gross C. Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Exp. Neurol. 148 (1997) 288-292
5. Chung C.Y., Seo H., Sonntag K.C., Brooks A., Lin L., and Isacson O. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum. Mol. Genet. 14 (2005) 1709-1725
6. Cookson M.R. The biochemistry of parkinson's disease. Annu. Rev. Biochem. 74 (2005) 29-52
7. Coscoy L., and Ganem D. PHD domains and E3 ubiquitin ligases: viruses make the connection. Trends Cell Biol. 13 (2003) 7-12
8. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
9. Elsworth J.D., Deutch A.Y., Redmond Jr. D.E., Sladek Jr. J.R., and Roth R.H. Differential responsiveness to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. Life Sci. 40 (1987) 193-202
10. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
11. Gainetdinov R.R., Fumagalli F., Jones S.R., and Caron M.G. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J. Neurochem. 69 (1997) 1322-1325
12. Garcia-Gonzalo F.R., and Rosa J.L. The HERC proteins: functional and evolutionary insights. Cell. Mol. Life Sci. 62 (2005) 1826-1838
13. Garcia-Segura L.M., Perez J., Pons S., Rejas M.T., and Torres-Aleman I. Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 560 (1991) 167-174
14. Glover V., Gibb C., and Sandler M. The role of MAO in MPTP toxicity-a review. J. Neural Transm. Suppl. 20 (1986) 65-76
15. Gonzalez-Hernandez T., Barroso-Chinea P., De La Cruz Muros I., Del Mar Perez-Delgado M., and Rodriguez M. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J. Comp. Neurol. 479 (2004) 198-215
16. Greene J.G. Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J. Physiol. 575 (2006) 411-416
17. Greene J.G., Dingledine R., and Greenamyre J.T. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol. Dis. 18 (2005) 19-31
18. Hirsch E., Graybiel A.M., and Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in parkinson's disease. Nature 334 (1988) 345-348
19. Hung H.C., Tao P.L., and Lee E.H. 1-methyl-4-phenyl-pyridinium (MPP+) uptake does not explain the differential toxicity of MPP+ in the nigrostriatal and mesolimbic dopaminergic pathways. Neurosci. Lett. 196 (1995) 93-96
20. Ietta F., Wu Y., Winter J., Xu J., Wang J., Post M., and Caniggia I. Dynamic HIF1A regulation during human placental development. Biol. Reprod. 75 (2006) 112-121
21. Jacobowitz D.M., Burns R.S., Chiueh C.C., and Kopin I.J. N-methyl-4-phenyl-1, 2, 3, 6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey. Psychopharmacol. Bull. 20 (1984) 416-422
22. Kessler M.A., Yang M., Gollomp K.L., Jin H., and Iacovitti L. The human tyrosine hydroxylase gene promoter. Brain Res. Mol. Brain Res. 112 (2003) 8-23
23. Kopin I.J. MPTP effects on dopamine neurons. Ann. N. Y. Acad. Sci. 537 (1988) 451-461
24. Kotzbauer P.T., Truax A.C., Trojanowski J.Q., and Lee V.M. Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2. J. Neurosci. 25 (2005) 689-698
25. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
26. Langston J.W., Langston E.B., and Irwin I. MPTP-induced parkinsonism in human and non-human primates-clinical and experimental aspects. Acta Neurol. Scand. Suppl. 100 (1984) 49-54
27. Liang C.L., Sinton C.M., Sonsalla P.K., and German D.C. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 5 (1996) 313-318
28. Lu Z., Xu S., Joazeiro C., Cobb M.H., and Hunter T. The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol. Cell 9 (2002) 945-956
29. Mandel S., Grunblatt E., Riederer P., Amariglio N., Jacob-Hirsch J., Rechavi G., and Youdim M.B. Gene expression profiling of sporadic parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann. N. Y. Acad. Sci. 1053 (2005) 356-375
30. Massi M., Panocka I., and de Caro G. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides 21 (2000) 1597-1609
31. McCaffery P., and Drager U.C. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7772-7776
32. Miller R.M., and Federoff H.J. Altered gene expression profiles reveal similarities and differences between parkinson disease and model systems. Neuroscientist 11 (2005) 539-549
33. Miller R.M., Callahan L.M., Casaceli C., Chen L., Kiser G.L., Chui B., Kaysser-Kranich T.M., Sendera T.J., Palaniappan C., and Federoff H.J. Dysregulation of gene expression in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse substantia nigra. J. Neurosci. 24 (2004) 7445-7454
34. Raisanen S.R., Lehenkari P., Tasanen M., Rahkila P., Harkonen P.L., and Vaananen H.K. Carbonic anhydrase III protects cells from hydrogen peroxide-induced apoptosis. FASEB J. 13 (1999) 513-522
35. Ramsay R.R., Kowal A.T., Johnson M.K., Salach J.I., and Singer T.P. The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase. Arch. Biochem. Biophys. 259 (1987) 645-649
36. Reynolds A., Laurie C., Lee Mosley R., and Gendelman H.E. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol. 82 (2007) 297-325
37. Scheel H., and Hofmann K. No evidence for PHD fingers as ubiquitin ligases. Trends Cell Biol. 13 (2003) 285-287 author reply 287-8
38. Schein J.C., Hunter D.D., and Roffler-Tarlov S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev. Biol. 204 (1998) 432-450
39. Scheller D., Stichel-Gunkel C., Lubbert H., Porras G., Ravenscroft P., Hill M., and Bezard E. Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of parkinson's disease. Neurosci. Lett. 432 (2008) 30-34
40. Schneider J.S., Yuwiler A., and Markham C.H. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP. Brain Res. 411 (1987) 144-150
41. Seroogy K.B., Lundgren K.H., Tran T.M., Guthrie K.M., Isackson P.J., and Gall C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342 (1994) 321-334
42. Shigemoto R., Ohishi H., Nakanishi S., and Mizuno N. Expression of the mRNA for the rat NMDA receptor (NMDAR1) in the sensory and autonomic ganglion neurons. Neurosci. Lett. 144 (1992) 229-232
43. Sly W.S., and Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 64 (1995) 375-401
44. Yang Z., Alvarez B.V., Chakarova C., Jiang L., Karan G., Frederick J.M., Zhao Y., Sauve Y., Li X., Zrenner E., Wissinger B., Hollander A.I., Katz B., Baehr W., Cremers F.P., Casey J.R., Bhattacharya S.S., and Zhang K. Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration. Hum. Mol. Genet. 14 (2005) 255-265
45. Zhang X., Zhou Z., Wang D., Li A., Yin Y., Gu X., Ding F., Zhen X., and Zhou J. Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2 expression in astrocytes via IP3-dependent Ca2+ signaling. J. Neurosci. 29 (2009) 7766-7775